Patients given whole-brain radiotherapy are at greater risk of decline in learning and memory function; therefore, stereotactic radiosurgery plus close clinical monitoring should be the standard initial treatment, according to results of a clinical trial published online Oct. 3, before the November edition of Lancet Oncology.